The limited proportion of chemical products exports needs to improve international competitiveness

[market analysis of chinapharma.com] according to the data of the analysis report on the production and marketing demand and investment forecast of China's chemical pharmaceutical industry released by the prospective industry research institute, in recent years, the export volume of China's chemical pharmaceutical industry has exceeded US $3 billion, with a year-on-year growth rate of about 40%, and the number of export products has been increasing (the proportion of chemical products exported is limited, and the international competitiveness needs to be improved Picture source: Baidu picture) for a long time, China's chemical products have frequently encountered the problem of "going to sea", and the main export force is still API Until recent years, the export volume of chemical preparations has increased rapidly, but the proportion is still limited In the future, it is necessary to further improve the international competitiveness and gain more overseas market share The so-called chemical pharmaceutical preparations refer to the chemical pharmaceutical preparations directly used for the prevention, treatment and diagnosis of human diseases, which generally belong to the same category as western pharmaceutical preparations and Western patent medicines After years of development, China's chemical preparation production technology has made rapid progress, while satisfying domestic supply, it continues to attack cities and plunder land overseas, and the export volume is rising Chemical preparations: according to the data of the forecast and analysis report on the production and marketing demand and investment of China's chemical preparations Industry issued by the prospective industry research institute, in recent years, the export volume of China's chemical preparations has exceeded 3 billion US dollars, with a year-on-year growth rate of about 40%, and the types of export products are also increasing However, on the whole, it is still difficult for chemicals to go abroad, and there is a long way to go in the future First of all, it is difficult to register abroad This is due to the direct effect of chemicals on patients, higher requirements for their quality standards, access threshold, and cumbersome registration procedures The whole registration process usually takes 3-4 years, or even longer, leading to greater risks for enterprises and low willingness to export Secondly, the ability of scientific research and development is insufficient At present, most of the chemicals exported by our country are generic drugs, and the added value of the products is low, so it is difficult to create an international brand The reason lies in the lack of R & D investment and new drug research resources After that, the export variety is single In fact, China has already become a big producer of APIs in the world However, due to technical limitations, the products that can be exported are limited, which are concentrated in artemisinin, cephalosporins, vitamins, hormones and other drugs Therefore, in order to expand the export of chemicals and improve international competitiveness First, we need to speed up international certification and break the bottleneck in the export of pharmaceutical preparations In order to obtain international certification, we need to start from our own internal, cultivate talents, build high standard workshops, and implement production in accordance with foreign requirements Second, we need to improve the variety of preparations and make full use of the existing advantages in R & D, management and operation of APIs We can make full use of the advantages of APIs, improve the varieties of preparations, and expand the business in the international market Third, we should enhance our ability of independent innovation and vigorously develop local brands Independent innovation is the fundamental way for chemical preparation enterprises to go out of international competition Since the development of chemical pharmaceutical industry, it is necessary to gradually get rid of the imitation mode, highlight independent innovation and integrate technical resources in order to create a local pharmaceutical brand.